# Efficacy and Safety of Lithium Carbonate in the Treatment of Chronic Spinal Cord Injuries

> **NCT00750061** · PHASE2 · COMPLETED · sponsor: **China Spinal Cord Injury Network** · enrollment: 40 (actual)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00750061
- **Lead sponsor:** China Spinal Cord Injury Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750061, "Efficacy and Safety of Lithium Carbonate in the Treatment of Chronic Spinal Cord Injuries". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00750061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*